Anti-Aging Drugs and the Related Signal Pathways

Nannan Du,Ruigang Yang,Shengrong Jiang,Zubiao Niu,Wenzhao Zhou,Chenyu Liu,Lihua Gao,Qiang Sun

DOI: https://doi.org/10.3390/biomedicines12010127

IF: 4.757

2024-01-10

Biomedicines

Abstract:Aging is a multifactorial biological process involving chronic diseases that manifest from the molecular level to the systemic level. From its inception to 31 May 2022, this study searched the PubMed, Web of Science, EBSCO, and Cochrane library databases to identify relevant research from 15,983 articles. Multiple approaches have been employed to combat aging, such as dietary restriction (DR), exercise, exchanging circulating factors, gene therapy, and anti-aging drugs. Among them, anti-aging drugs are advantageous in their ease of adherence and wide prevalence. Despite a shared functional output of aging alleviation, the current anti-aging drugs target different signal pathways that frequently cross-talk with each other. At present, six important signal pathways were identified as being critical in the aging process, including pathways for the mechanistic target of rapamycin (mTOR), AMP-activated protein kinase (AMPK), nutrient signal pathway, silent information regulator factor 2-related enzyme 1 (SIRT1), regulation of telomere length and glycogen synthase kinase-3 (GSK-3), and energy metabolism. These signal pathways could be targeted by many anti-aging drugs, with the corresponding representatives of rapamycin, metformin, acarbose, nicotinamide adenine dinucleotide (NAD+), lithium, and nonsteroidal anti-inflammatory drugs (NSAIDs), respectively. This review summarized these important aging-related signal pathways and their representative targeting drugs in attempts to obtain insights into and promote the development of mechanism-based anti-aging strategies.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy

What problem does this paper attempt to address?

The paper primarily explores anti-aging drugs and their related signaling pathways. The research aims to summarize the currently known key signaling pathways that can influence the aging process and discuss representative anti-aging drugs targeting these pathways.

Specifically, the article first introduces the health challenges brought by an aging society, including the increase in chronic diseases. To address these issues, researchers have explored various anti-aging strategies such as dietary restriction (DR), exercise, circulating factor exchange, gene therapy, and anti-aging drugs. Among these, anti-aging drugs have garnered attention due to their ease of implementation and wide applicability.

The article further identifies six important signaling pathways considered to play a key role in the aging process:
1. **mTOR signaling pathway**: Influences lifespan by regulating processes such as protein homeostasis, mitochondrial respiration, autophagy, and endoplasmic reticulum stress.
2. **AMPK signaling pathway**: Extends lifespan by affecting mechanisms such as cellular stress resistance, cell growth, autophagy, and inflammation.
3. **Nutritional signaling pathways**: For example, regulating lifespan through molecules like short-chain fatty acids (SCFAs) and ATF4.
4. **SIRT1 signaling pathway**: Related to NAD+, regulates aging through the deacetylase SIRT1.
5. **Telomere length and GSK-3 regulatory signaling pathways**: Although this part is not detailed in the provided text, it can be inferred that such pathways may involve factors like telomere stability and cell cycle regulation.
6. **Energy metabolism-related signaling pathways**: This may also influence the rate of aging by regulating metabolic pathways.

Each pathway has a class of representative anti-aging drugs, such as rapamycin, metformin, acarbose, nicotinamide adenine dinucleotide (NAD+), lithium salts, and non-steroidal anti-inflammatory drugs (NSAIDs). These drugs act on the aforementioned signaling pathways through different mechanisms to achieve anti-aging effects.

In summary, this paper aims to comprehensively summarize the current understanding of anti-aging drugs and explore how they can delay the aging process through specific signaling pathways.